Stroke Trial, Recruiting NCT06416371 Sponsor: University of Edinburgh Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06416371
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are already part of a research group called the Mild Stroke Study 3 cohort
  • People who have had an MRI scan with contrast dye within the last 12 months
  • People whose eyes are clear enough to be examined, as checked by a study investigator
  • People whose near vision, when wearing glasses or contact lenses if needed, meets the minimum level required for this trial (confirm with trial site)

Who may not be able to join:

  • People who have a condition known to cause fluid leakage in the retina, such as more than mild diabetic eye disease, a blocked vein in the retina, active eye inflammation, the wet form of age-related macular degeneration, or severely high blood pressure affecting the eyes
  • People who have previously had treatment for retinal leakage, such as laser therapy to the retina or injections into the eye
  • People who have had eye surgery recently
  • People who have been found to have a certain type of narrow structure at the front of the eye, as checked by a torch test (confirm with trial site)
  • People who are pregnant or have kidney failure
  • People with severe dementia
  • People who have a known allergy to a dye called fluorescein
  • People who have a history of allergic reactions such as hives from food or medication, or a history of asthma
  • People with any other serious or severe medical or mental health conditions
  • People who are not able to give informed consent to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Edinburgh
Registry
ClinicalTrials.gov
Start date
13 January 2025
Est. completion
15 February 2029

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Retinal vessel leakage by automated segmentation; Retinal vessel leakage by manual grading

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov